International Conferences and Seminars


 Parham    09 Sep 2017 : 14:55

FASEB_2.jpg

Selected conferences

Kaboli, PJ et al. (2017) Molecular modelling, molecular dynamics simulations and in vitro evaluation of Berberine as an inhibitor of MAP kinase and PI3K pathway. EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno and Targeted Therapies: From Cancer Biology to the Clinic, 25th June 2017, Florence, Italy.

(Role: Poster presenter; Session Title: Experimental/Molecular Therapeutics)

Kaboli, PJ et al. (2017) Molecular modelling of berberine derivatives as inhibitors of smoothened receptor using a new drug discovery script for a large numbers of compounds. EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno and Targeted Therapies: From Cancer Biology to the Clinic, 25th June 2017, Florence, Italy.

(Role: Poster presenter; Session Title: Experimental/Molecular Therapeutics)

Kaboli, PJ et al. (2017) Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation. Experimental Biology, ASPET annual meeting, 23th April 2017, Chicago, USA.

(Role: Poster presenter; Session Title: Cell Signaling and Cancer Therapeutics)

Kaboli, PJ et al. (2017) A Novel One-Click Automated Drug Discovery tool: A New Approach Based on Binding Efficiency indices. Experimental Biology, ASPET annual meeting, 24th April 2017, Chicago, USA.

(Role: Poster presenter; Session Title: Drug Discovery and Development: Discovery Technology Platforms)

Kaboli, PJ et al. (2016) Molecular modelling and molecular dynamics simulations of berberine derivative as a dual RAF inhibitor for treatment of drug resistance acquired in melanoma. (Abstract) BPS Pharmacology 2016, 13th December 2016, London, UK.

(Role: Oral presenter; Session Title: Drug Discovery, Development & Evaluation)